Fewer PSA Tests May Benefit Older, Low-Risk Prostate Cancer Survivors, Study Says

Fewer PSA Tests May Benefit Older, Low-Risk Prostate Cancer Survivors, Study Says
A new study suggests that older patients who survived prostate cancer with a low risk of recurrence could benefit from fewer prostate cancer antigen (PSA) tests, as they are more likely to experience the harmful effects of PSA monitoring that could outweigh the advantages. The study, “Individualizing PSA Monitoring Among Older Prostate Cancer Survivors,” was

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *